Breast Cancer Symposium in San Antonio presents positive results
Jun 8, 2011
At the 2011 San Antonio Breast Cancer Symposium, Genomic Health Inc. has announced positive results concerning their Oncotype DX study with breast cancer patients.
The study results concern ductal carinoma in situ of the breast (DCIS). The research was done in clinical trials sponsored by the National Cancer Institute.
"The preliminary results of this trial show for the first time that a multi-gene assay can identify lower risk DCIS which may be treated with surgery alone, and higher risk DCIS for which radiation therapy should be considered in addition to surgery," said Dr. Lawrence J. Solin, the Principal Investigator and Chairman of the Department of Radiation Oncology at Albert Einstein Medical Center in Philadelphia.
Breast cancer is the second most common type of cancer in women in the U.S., after skin cancer, according to the American Cancer Society. More than 200,000 women are newly diagnosed with the illness each year, while almost 2,000 men are diagnosed with the disease. Women over the age of 40 should have yearly mammograms in order to find cancer at its earliest onset, according to the ACS.